In their recently published pooled analysis of four drugcoated balloon (DCB) studies, which focused on the impact of patient and lesion characteristics on LLL at 6 months (Albrecht T et al. Cardiovasc Intervent Radiol. 2018 Dec 11. https://doi.org/10.1007/s00270-018-2137-3), the authors reported slightly inaccurate 2-year mortality rates. We would like to rectify this. The discrepancies were as follows: The correct mortality rates are 7.0% for the control group and 8.6% for the DCB group (p = 0.55), while the authors erroneously reported these rates as 5.5% (controls) and 7.9% (DCB, p = 0.32). The reason for these discrepancies was mainly the imprecise calculation of the number of patients available for 2-year follow-up. Details can be found in a follow-up paper published recently in CVIR (Albrecht T, Schnorr B, Kutschera M et al. Cardiovasc Intervent Radiol. 2019 . https://doi.org/10.1007/ s00270-019-02194-w).
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